Biliary obstruction selectively expands and activates liver myeloid dendritic cells

Journal of Immunology

Volumn 176, Issue 12, 2006, Pages 7189-7195

  Bleier, Joshua I ^a   Katz, Steven C ^a   Chaudhry, Umer I ^a   Pillarisetty, Venu G ^a   Kingham III, T Peter ^a   Shah, Alaap B ^a   Raab, Jesse R ^a   DeMatteo, Ronald P ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT LIGATION; BILE DUCT OBSTRUCTION; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; HEPATITIS; IMMUNE RESPONSE; IMMUNOREGULATION; LAPAROTOMY; LIVER FIBROSIS; MALE; MOUSE; NONHUMAN; OBSTRUCTIVE JAUNDICE; PRIORITY JOURNAL; PROTEIN FUNCTION; T LYMPHOCYTE ACTIVATION;

EID: 33744945790     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.12.7189     Document Type: Article

References (36)

1. Armstrong, C. P., J. M. Dixon, T. V. Taylor, and G. C. Davies. 1984. Surgical experience of deeply jaundiced patients with bile duct obstruction. Br. J. Surg. 71: 234-248.
2. Dixon, J. M., C. P. Armstrong, S. W. Duffy, and G. C. Davies. 1983. Factors affecting morbidity and mortality after surgery for obstructive jaundice: a review of 373 patients. Gut 24: 845-852.
3. Greve, J. W., D. J. Gouma, P. B. Soeters, and W. A. Buurman. 1990. Suppression of cellular immunity in obstructive jaundice is caused by endotoxins: a study with germ-free rats. Gastroenterology 98: 478-485.
4. Haga, Y., M. A. Tempero, and R. K. Zetterman. 1996. Unconjugated bilirubin inhibits in vitro cytotoxic T lymphocyte activity of human lymphocytes. Biochim. Biophys. Acta 1317: 65-70.
5. Pain, J. A. 1987. Reticulo-endothelial function in obstructive jaundice. Br. J. Surg. 74: 1091-1094.
6. Abe, T., T. Arai, A. Ogawa, T. Hiromatsu, A. Masuda, T. Matsuguchi, Y. Nimura, and Y. Yoshikai. 2004. Kupffer cell-derived interleukin 10 is responsible for impaired bacterial clearance in bile duct-ligated mice. Hepatology 40: 414-423.
7. Levy, R., F. Schlaeffer, A. Keynan, O. Nagauker, A. Yaari, and E. Sikuler. 1993. Increased neutrophil function induced by bile duct ligation in a rat model. Hepatology 17: 908-914.
8. Gujral, J. S., A. Farhood, M. L. Bajt, and H. Jaeschke. 2003. Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice. Hepatology 38: 355-363.
9. Thomson, A. W., M. L. Drakes, A. F. Zahorchak, P. J. O'Connell, R. J. Steptoe, S. Qian, and L. Lu. 1999. Hepatic dendritic cells: immunobiology and role in liver transplantation. J. Leukocyte Biol. 66: 322-330.
10. Thomson, A. W., P. J. O'Connell, R. J. Steptoe, and L. Lu. 2002. Immunobiology of liver dendritic cells. Immunol. Cell Biol. 80: 65-73.
11. Steinman, R. M. 2003. Some interfaces of dendritic cell biology. APMIS 111: 675-697.
12. Steinman, R. M., D. Hawiger, and M. C. Nussenzweig. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21: 685-711.
13. Pillarisetty, V. G., A. B. Shah, G. Miller, J. I. Bleier, and R. P. DeMatteo. 2004. Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition. J. Immunol. 172: 1009-1017.
14. Jomantaite, I., N. Dikopoulos, A. Kroger, F. Leithauser, H. Hauser, R. Schirmbeck, and J. Reimann. 2004. Hepatic dendritic cell subsets in the mouse. Eur. J. Immunol. 34: 355-365.
15. Lian, Z. X., T. Okada, X. S. He, H. Kita, Y. J. Liu, A. A. Ansari, K. Kikuchi, S. Ikehara, and M. E. Gershwin. 2003. Heterogeneity of dendritic cells in the mouse liver: identification and characterization of four distinct populations. J. Immunol. 170: 2323-2330.
16. Woo, J., L. Lu, A. S. Rao, Y. Li, V. Subbotin, T. E. Starzl, and A. W. Thomson. 1994. Isolation, phenotype, and allostimulatory activity of mouse liver dendritic cells. Transplantation 58: 484-491.
17. Johansson, C., and M. J. Wick. 2004. Liver dendritic cells present bacterial antigens and produce cytokines upon Salmonella encounter. J. Immunol. 172: 2496-2503.
18. Miller, G., V. G. Pillarisetty, A. B. Shah, S. Lahrs, Z. Xing, and R. P. DeMatteo. 2002. Endogenous granulocyte-macrophage colony-stimulating factor overexpression in vivo results in the long-term recruitment of a distinct dendritic cell population with enhanced immunostimulatory function. J. Immunol. 169: 2875-2885.
19. Katz, S. C., V. G. Pillarisetty, J. I. Bleier, A. B. Shah, and R. P. DeMatteo. 2004. Liver sinusoidal endothelial cells are insufficient to activate T cells. J. Immunol. 173: 230-235.
20. Fujiwara, Y., M. Shimada, Y. Yamashita, E. Adachi, K. Shirabe, K. Takenaka, and K. Sugimachi. 2001. Cytokine characteristics of jaundice in mouse liver. Cytokine 13: 188-191.
21. Bemelmans, M. H., D. J. Gouma, J. W. Greve, and W. A. Buurman. 1992. Cytokines tumor necrosis factor and interleukin-6 in experimental biliary obstruction in mice. Hepatology 15: 1132-1136.
22. Bleier, J. I., V. G. Pillarisetty, A. B. Shah, and R. P. DeMatteo. 2004. Increased and long-term generation of dendritic cells with reduced function from IL-6-deficient bone marrow. J. Immunol. 172: 7408-7416.
23. Ezure, T., T. Sakamoto, H. Tsuji, J. G. Lunz III, N. Murase, J. J. Fung, and A. J. Demetris. 2000. The development and compensation of biliary cirrhosis in interleukin-6-deficient mice. Am. J. Pathol. 156: 1627-1639.
24. Xu, L. L., M. K. Warren, W. L. Rose, W. Gong, and J. M. Wang. 1996. Human recombinant monocyte chemotactic protein and other C-C chemokines bind and induce directional migration of dendritic cells in vitro. J. Leukocyte Biol. 60: 365-371.
25. Pashenkov, M., N. Teleshova, M. Kouwenhoven, T. Smimova, Y. P. Jin, V. Kostulas, Y. M. Huang, B. Pinegin, A. Boiko, and H. Link. 2002. Recruitment of dendritic cells to the cerebrospinal fluid in bacterial neuroinfections. J. Neuroimmunol. 122: 106-116.
26. Ross, E. L., D. D'Cruz, and W. J. Morrow. 2000. Localized monocyte chemotactic protein-1 production correlates with T cell infiltration of synovium in patients with psoriatic arthritis. J. Rheumatol. 27: 2432-2443.
27. Masten, B. J., G. K. Olson, D. F. Kusewitt, and M. F. Lipscomb. 2004. Flt3 ligand preferentially increases the number of functionally active myeloid dendritic cells in the lungs of mice. J. Immunol. 172: 4077-4083.
28. Pillarisetty, V. G., G. Miller, A. B. Shah, and R. P. DeMatteo. 2003. GM-CSF expands dendritic cells and their progenitors in mouse liver. Hepatology 37: 641-652.
29. + dendritic cells expressing indoleamine 2,3-dioxygenase. J. Immunol. 167: 708-714.
30. Scott-Conner, C. E., and J. B. Grogan. 1994. The pathophysiology of biliary obstruction and its effect on phagocytic and immune function. J. Surg. Res. 57: 316-336.
31. Chiu, B. C., C. M. Freeman, V. R. Stolberg, J. S. Hu, K. Zeibecoglou, B. Lu, C. Gerard, I. F. Charo, S. A. Lira, and S. W. Chensue. 2004. Impaired lung dendritic cell-activation in CCR2 knockout mice. Am. J. Pathol. 165: 1199-1209.
32. Sitia, G., M. Isogawa, K. Kakimi, S. F. Wieland, F. V. Chisari, and L. G. Guidotti. 2002. Depletion of neutrophils blocks the recruitment of antigen-nonspecific cells into the liver without affecting the antiviral activity of hepatitis B virus-specific cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 99: 13717-13722.
33. Saito, J. M., and J. J. Maher. 2000. Bile duct ligation in rats induces biliary expression of cytokine-induced neutrophil chemoattractant. Gastroenterology 118: 1157-1168.
34. Friedman, S. L. 2004. Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications. Nat. Clin. Pract. Gastroenterol. Hepatol. 1: 98-105.
35. Leung, P. S., R. L. Coppel, and M. E. Gershwin. 2005. Etiology of primary biliary cirrhosis: the search for the culprit. Semin. Liver Dis. 25: 327-336.
36. Leung, P. S., R. L. Coppel, and M. E. Gershwin. Semin. Liver Dis. Vol. 176 No. 12